U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad

retained text

The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23

document fetched 2026-10-24 15:22 · canonical https://thehindu.com/business/Industry/us-fda-issues-four-observations-to-gland-pharma-formulation-facility-near-hyderabad/article71616791.ece